Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Barbara Sterle Zorec"'
Autor:
Barbara Sterle Zorec, Rok Dreu
Publikováno v:
Zdravniški Vestnik, Vol 92, Iss 5-6, Pp 221-232 (2023)
Pomen personaliziranega načina zdravljenja se iz leta v leto povečuje, saj je zavedanje, da ljudje nismo popolnoma enaki in da vsak organizem potrebuje sebi lastno terapijo, vedno večje. Poznavanje genetike in njenega vpliva na izvor in potek neka
Externí odkaz:
https://doaj.org/article/e002ec4581ff4fbb8d6da2001bad5138
Autor:
Barbara Sterle Zorec, Rok Dreu
Publikováno v:
Pharmaceutics, Vol 15, Iss 9, p 2221 (2023)
In this work, a spray drying method was developed to produce drug/polymer (simvastatin/polycaprolactone) microparticles that have the potential to be used as a pre-formulation for ex tempore preparation of 2D printing cartridges. An experimental mode
Externí odkaz:
https://doaj.org/article/2cd075e2a2c94cae92c21ca23cba1628
Publikováno v:
Pharmaceutics, Vol 15, Iss 7, p 1918 (2023)
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by impaired skin barrier function. Amongst the various dermal formulations that are being used and/or investigated for AD treatment, one of the advanced approaches is the use
Externí odkaz:
https://doaj.org/article/f0e88d2fc4844e25a6ef8d42f2fed1c7
Autor:
Rok Dreu, Barbara Sterle Zorec
Publikováno v:
Slovenian Medical Journal. :1-12
Pomen personaliziranega načina zdravljenja se iz leta v leto povečuje, saj je zavedanje, da ljudje nismo popolnoma enaki in da vsak organizem potrebuje sebi lastno terapijo, vedno večje. Poznavanje genetike in njenega vpliva na izvor in potek neka
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40d9fe9298da27b4874fe85dcc95526d
https://doi.org/10.6016/zdravvestn.3347
https://doi.org/10.6016/zdravvestn.3347
Publikováno v:
Pharmaceutics; Volume 15; Issue 7; Pages: 1918
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by impaired skin barrier function. Amongst the various dermal formulations that are being used and/or investigated for AD treatment, one of the advanced approaches is the use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::dda18ab9d3e8dbedaf5edbf34f52152b
Autor:
Zorec, Barbara Sterle1 barbara.sterle.zorec@ffa.uni-lj.si, Dreu, Rok1
Publikováno v:
Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten. 2023 Supplement, Vol. 69, p27-28. 2p.
Autor:
Sterle Zorec, Barbara1 (AUTHOR) barbara.sterle.zorec@ffa.uni-lj.si, Dreu, Rok1 (AUTHOR)
Publikováno v:
Pharmaceutics. Sep2023, Vol. 15 Issue 9, p2221. 22p.
Autor:
Bolko Seljak, Katarina1 (AUTHOR) katarina.bolko-seljak@ffa.uni-lj.si, Sterle Zorec, Barbara1 (AUTHOR), Gosenca Matjaž, Mirjam1 (AUTHOR) mirjam.gosenca.matjaz@ffa.uni-lj.si
Publikováno v:
Pharmaceutics. Jul2023, Vol. 15 Issue 7, p1918. 21p.
Autor:
Sterle Zorec, Barbara1 (AUTHOR) barbara.sterle.zorec@ffa.uni-lj.si
Publikováno v:
Pharmaceutical Development & Technology. Nov2023, Vol. 28 Issue 9, p826-842. 17p.
Publikováno v:
Drug Week; 10/13/2023, p2007-2007, 1p